Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

Share Price is delayed by 15 minutes
Get Live Data
75.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (6.849%)
Market Cap: £10.10m
ARC Live PriceLast checked at - London Stock Exchange

Intraday Arcontech Group Share Chart

Half Yearly Report

24 Feb 2016 07:00

RNS Number : 9335P
Arcontech Group PLC
24 February 2016
 

 

 

 

ARCONTECH GROUP PLC

 

("Arcontech" or the "Group")

 

INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2015

 

 

Arcontech (AIM: ARC), the provider of products and services for real-time financial market data processing and trading, is pleased to report its unaudited results for the six months ended 31 December 2015.

 

Financial and business highlights:

 

· Turnover increased by 9% to £1,132,246 (six months ended 31 December 2014: £1,041,599).

· Operating profit increased by 78% to £205,889 (six months ended 31 December 2014: £115,900).

· Annual run-rate of recurring revenues at 31 December 2015 amount to £1.9 million (2014: £2.1 million) and cover 105% of the cost base (2014: 112%).

· Net cash of £1,538,519 as at 31 December 2015 (31 December 2014: £1,073,948).

 

Richard Last, Chairman of Arcontech Group, said:

 

"The Board is pleased to report continued progress by the Group in delivering increasing levels of turnover and profitability. Results for the current year ending 30 June 2016 remain on target taking into account the reduced revenue from one of our clients in Asia. Costs continue to be managed closely. With net cash balances as at 22 February 2016 of £1.8m and a good sales pipeline, we are increasingly positive about the Group's prospects."

 

 

Enquiries:

 

Arcontech Group plc

 

Richard Last, Chairman and Non-Executive Director

07713 214484

Matthew Jeffs, Chief Executive

020 7256 2300

 

 

finnCap Ltd

 

Carl Holmes/Simon Hicks

020 7220 0569

 

 

To access more information on the Group please visit: www.arcontech.com

 

The interim report will only be available to view online enabling the Group to communicate in a more environmentally friendly and cost effective manner.

 

Chairman's Statement

 

I am pleased to report that Arcontech has continued to grow profits in the six months ended 31 December 2015. The operating profit for the period was £205,889 compared to £115,900 in the corresponding six month period ended 31 December 2014, an increase of 78%. This was achieved by increasing turnover for the six month period by 9% to £1.13 million (six month period ended 31 December 2014: £1.04 million) and by continued strict cost control. Of the total revenue, £1.13 million relates to recurring annual licence fees (six month period ended 31 December 2014: £1.04 million). Fully diluted earnings per share increased by 42% to 0.02 pence per share compared to 0.014 pence per share for the corresponding period last year.

 

We continue to work towards making up for the termination of a significant contract with an Asia focused bank (as announced on 26th March 2015) requesting the termination of its contract 18 months early, and which was agreed to take effect from 1 January 2016. Despite this loss, the annual run-rate of recurring revenues at 31 December 2015 (excluding that contract) amounts to £1.9 million (2014: £2.1 million including that contract) and covers 105% of the cost base (2014: 112%).

 

The sales cycle continues to be longer than we would like. With our strengthened pipeline of qualified prospects, along with the additional offerings under development we believe the frequency of new sales wins will improve. Our product development continues to focus both on enhancing solutions for existing customers, as well as developing new products and is showing good progress. We have been working with several clients to broaden the appeal of Excelerator as well as enhance our server-side systems to better integrate with clients' infrastructure.

 

Financing

Arcontech has net cash balances at 31 December 2015 of £1,538,519 (31 December 2014: £1,073,948). This has allowed Arcontech to continue to maintain its level of product development and further increase its sales capability. Cash balances at 22nd February amount to £1,803,370.

 

Employees

I should like to thank our employees and my fellow directors for their continuing hard work and dedication over the last six months, without which we would not have been able to achieve the reported results and to increase profitability.

 

Outlook

The Board is pleased to report continued progress by the Group in delivering increasing levels of turnover and profitability. Results for the current year ending 30 June 2016 remain on target taking into account the reduced revenue from one of our clients in Asia. Costs continue to be managed closely. With net cash balances as at 22 February 2016 of £1.8m and a good sales pipeline, we are increasingly positive about the Group's prospects.

 

 

Richard Last

Chairman and Non-Executive Director

 

 

GROUP INCOME STATEMENT AND STATEMENT OF COMPREHENSIVE INCOME

 

 

Six months ended 31

 December

Six months ended 31

 December

Year ended

30 June

 

2015

2014

2015

(unaudited)

(unaudited)

(audited)

£

£

£

Revenue

1,132,246

1,041,599

2,129,958

Administrative costs

(926,657)

(925,699)

(1,890,242)

Operating profit

205,589

115,900

239,716

Finance income

4,071

1,032

3,944

Profit before taxation

209,660

116,932

243,660

Taxation

105,813

109,378

109,378

 

Profit for the period after tax

 

 

315,473

226,310

 

353,038

Total comprehensive income

315,473

226,310

353,038

Profit per share (basic)

0.021p

0.015p

0.023p

Profit per share (diluted)

0.020p

0.014p

0.023p

 

All of the results relate to continuing operations.

 

  

 

 

 

 

BALANCE SHEETS

 

 

 

31 December

 

 

31 December

 

 

30 June

 

2015

2014

2015

(unaudited)

(unaudited)

(audited)

£

£

£

Non-current assets

Goodwill

1,715,153

1,715,153

1,715,153

Property, plant and equipment

49,840

15,531

41,605

Trade and other receivables

141,750

-

141,750

Total non-current assets

1,906,743

1,730,684

1,898,508

Current assets

Trade and other receivables

589,294

757,616

478,402

Cash and cash equivalents

1,538,519

1,073,948

1,069,755

Total current assets

2,127,813

1,831,564

1,548,157

Current liabilities

Trade and other payables

(609,223)

(609,224)

(779,542)

Deferred income

(1,306,273)

(1,303,096)

(877,001)

Total current liabilities

(1,915,496)

(1,912,320)

(1,656,543)

Net current assets/(liabilities)

212,317

(80,756)

(108,386)

Net assets

2,119,060

1,649,928

1,790,122

Equity

Share capital

1,536,672

1,536,672

1,536,672

Share premium account

9,430,312

9,430,312

9,430,312

Share option reserve

106,226

79,295

92,761

Retained earnings

(8,954,150)

(9,396,351)

(9,269,623)

2,119,060

1,649,928

1,790,122

 

 

 

 

 

 

 

GROUP CASH FLOW STATEMENT

 

 

Six months ended 31

December

Six months ended 31

December

Year ended

30 June

 

2015

2014

2015

(unaudited)

(unaudited)

(audited)

£

£

£

 

Net cash generated from operating activities

481,898

340,259

 

 

369,982

Investing activities

Interest received

4,071

1,032

3,944

 

Sales of plant and equipment

 

-

 

166

 

167

 

Purchases of plant and equipment

 

(17,205)

 

(1,185)

 

(38,014)

Net cash (used in)/generated from investing activities

 

(13,134)

 

13

(33,903)

 

 

Net increase in cash and cash equivalents

 

 

468,764

 

 

340,272

 

 

336,079

Cash and cash equivalents at beginning of period

 

1,069,755

 

733,676

 

733,676

Cash and cash equivalents at end of period

1,538,519

1,073,948

1,069,755

 

  

 

 

STATEMENT OF CHANGES IN EQUITY 

 

Share

capital

Share

premium

Share-based paymentsreserve

Retained

earnings

Total

£

£

£

£

£

At 1 July 2014

 

1,536,672

 

9,430,312

 

72,562

 

(9,622,661)

 

1,416,885

Total comprehensive income for the period

 

-

 

 

-

 

 

-

 

 

226,310

 

226,310

Share-based payments

 

-

 

-

 

6,733

 

-

 

6,733

At 31 December 2014

1,536,672

9,430,312

79,295

(9,396,351)

1,649,928

Total comprehensive income for the period

 - 

 

- 

 

- 

 126,728

 

126,728 

Share-based payments

 

-

 

-

 

13,466

 

-

13,466

At 30 June 2015

1,536,672

9,430,312

92,761

(9,269,623)

1,790,122

Total comprehensive income for the period

 

- 

 

-

 

- 

 

315,473 

 

315,473 

Share-based payments

 

-

-

 

13,465

 

-

 

13,465 

At 31 December 2015

1,536,672

9,430,312

106,226

(8,954,150)

2,119,060

 

 

 

 

 

 

NOTES TO THE FINANCIAL INFORMATION

 

1. The figures for the six months ended 31 December 2015 and 31 December 2014 are unaudited and do not constitute statutory accounts. The interim results have been prepared using accounting policies which are consistent with International Financial Reporting Standards as adopted by the European Union and are expected to be adopted in the next annual accounts.

2. The financial information for the year ended 30 June 2015 set out in this interim report does not comprise the Group's statutory accounts as defined in section 434 of the Companies Act 2006. The statutory accounts for the year ended 30 June 2015, which were prepared under International Financial Reporting Standards (IFRS) as adopted for use in the EU, applied in accordance with the provisions of the Companies Act 2006, have been delivered to the Registrar of Companies. The auditors reported on those accounts; their report was unqualified and did not contain a statement under either Section 498(2) or Section 498(3) of the Companies Act 2006 and did not include references to any matters to which the auditor drew attention by way of emphasis.

3. Copies of this statement are available from the Company Secretary at the Company's registered office at 1st Floor 11-21 Paul Street, London, EC2A 4JU or from the Company's website at www.arcontech.com.

4. Earnings per share have been calculated based on the profit after tax and the weighted average number of shares in issue during the half year ended 31 December 2015 of 1,536,672,013 (31 December 2014: 1,536,672,013; 30 June 2015: 1,536,672,013). The number of dilutive shares under option at 31 December 2015 was 22,187,953 (31 December 2014: 56,247,024; 30 June 2015: 15,602,834).The calculation of diluted earnings per share assumes conversion of all potentially dilutive ordinary shares, all of which arise from share options. A calculation is done to determine the number of shares that could have been acquired at the average market price during the period, based upon the issue price of the outstanding share options including future charges to be recognised under the share based payment arrangements.

5. Taxation is based on the unaudited results and provision has been estimated at the rate applicable to the Company at the time of this statement and expected to be applied to the total annual earnings. No corporation tax has been charged in the period as any liability has been offset against tax losses brought forward from prior years. The tax credit represents the cash recovery of Research & Development tax credits during the period.

6. There were no dividends paid or proposed during the period (2014: Nil).

7. The Directors have elected not to apply IAS34 Interim financial reporting.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR DMGZZRFLGVZM
Date   Source Headline
26th Jul 20107:00 amRNSPreliminary Results
14th Jun 20101:27 pmRNSHolding(s) in Company
16th Apr 20107:00 amRNSExcelerator Version 3 Release
15th Apr 20106:20 pmRNSHolding(s) in Company
26th Mar 20107:00 amRNSHalf Yearly Report
14th Dec 20097:00 amRNSNew Contract
11th Dec 20097:00 amRNSNew Director of Sales and Marketing
27th Nov 20097:00 amRNSNew Contract
9th Nov 200911:04 amRNSHolding(s) in Company
9th Nov 200910:55 amRNSHolding(s) in Company
4th Nov 200912:21 pmRNSHolding(s) in Company
29th Oct 20094:35 pmRNSResult of AGM
8th Oct 20098:31 amRNSHolding(s) in Company
6th Oct 20097:00 amRNSProduct Launch
21st Sep 20097:00 amRNSFinal Results
21st Sep 20097:00 amRNSPlacing to raise ?1.55 million
14th Jul 20097:00 amRNSIssue of Deferred Consideration
15th Jun 20097:00 amRNSChange of Name of Nominated Adviser and Broker
15th May 20097:00 amRNSStatement re CityVision
29th Apr 20097:00 amRNSArcontech's Excelerator finds favour in Europe
25th Mar 200912:38 pmRNSDirector/PDMR Shareholding
20th Mar 20097:00 amRNSHalf Yearly Report
23rd Feb 20097:00 amRNSChange of Name
28th Nov 20087:00 amRNSFinal Results
15th Sep 20087:00 amRNSStatement re Arcontech
22nd May 200812:30 pmRNSSale of MT Information Base
17th Apr 200811:47 amRNSHolding(s) in Company
15th Apr 20082:43 pmRNSHolding(s) in Company
10th Apr 200810:51 amRNSHolding(s) in Company
10th Apr 20087:00 amRNSDirector/PDMR Shareholding
4th Apr 20085:39 pmRNSDirector/PDMR Shareholding
4th Apr 20087:01 amRNSAdditional Listing
31st Mar 20087:02 amRNSInterim Results
11th Mar 20087:02 amRNSLaunch of New Website
3rd Mar 20087:02 amRNSExpansion of StarNet
17th Jan 20086:21 pmRNSRe Contract - Replacement
16th Jan 20087:01 amRNSRe Contract
18th Dec 20077:01 amRNSDirectorate Change
13th Dec 20079:48 amRNSHolding(s) in Company
10th Dec 200711:14 amRNSHolding(s) in Company
4th Dec 20077:01 amRNSFinal Results
20th Sep 20079:30 amRNSContract Win
5th Sep 20071:53 pmRNSHolding(s) in Company
3rd Sep 20072:11 pmRNSAdditional Listing
7th Aug 20077:01 amRNSAcquisition
19th Jul 20077:00 amRNSNew Best Execution Tool on MT
12th Jul 20079:54 amRNSStatement re Trading on PLUS
22nd Mar 20072:30 pmRNSHolding(s) in Company
12th Mar 20077:01 amRNSInterim Results
27th Feb 200711:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.